Growth Stock Wire Investment Newsletter

 
Growth Stock Wire Investment Newsletter About Growth Stock Wire Frequently Asked Questions Growth Stock Wire Archives Contact Us Privacy Policy
Print Edition | Also Visit: S&A Investment Research & DailyWealth
Friday, March 09, 2007

How to Make Correction-Proof Gains in 2007
By Rob Fannon, editor, The Medical Investor

It's become an investment cliché by now... for good reason.

If you've watched CNBC for more than 10 minutes in the past few weeks, you've probably heard a talking head telling you the best stocks to own during a market correction are "defensive" stocks...

Drugs... food... beer... This is the stuff folks are going to buy no matter what's going on in subprime lending or the U.S. dollar. What you're not hearing about is what I consider to be the epitome of a "defensive" sector: Medical devices.

---------- Advertisement ----------
$11,891 in 24 hours with "The Colorado Investment Jackpot"

The state of Colorado holds a powerful moneymaking secret... One that enables ordinary Americans to collect extraordinary jackpot payouts - $1,000, $5,000, sometimes even $10,000 - in as little as 24 hours.

In fact, the Chicago Daily Tribune reports in the past, a group of 99 people in one small town each collected $987,600 "overnight," thanks to this investment.

It’s no wonder The Wall Street Journal reported it's "the opportunity to risk a little and make a lot, somewhat like the Colorado lottery."

Click here for the full details.
------------------------------------

Medical devices really are a no-brainer place to park your money for the next decade... as baby boomers age and America's waistline expands, medical devices – like drug-coated heart stents, pacemakers, defibrillators, joint replacements, surgical tools, and diagnostic machines – are going to be more and more in demand.

The world's largest health care companies want to be ready for the boom. Last year, Boston Scientific (BSX) and Johnson & Johnson (JNJ) got into a heated bidding war for Guidant, which makes a laundry list of heart devices. BSX eventually prevailed, with its $27 billion offer. Have a fantastic new knee replacement idea? Johnson & Johnson would like to speak with you...

Public companies aren't the only ones pouring money into medical devices. Venture capital spending in medical device start-ups was up 25% in 2005. This number dwarfed investment levels in the biotech sector, which actually declined 7%. Early last year, Small Bone Innovations, which works in bone and joint replacements, fetched $42.2 million of VC money.

Private equity is jumping into the medical device boom, as well. In December, Biomet, which has the fourth-largest share of the hip- and knee-replacement market, agreed to a private-equity buyout for $10.9 billion.

Device companies offer premium-priced, high-margin products that can produce big cash flows. As a result, the sector attracted some heavy-hitting health care investors last year, like the Schwab Health Care mutual fund (SWHFX), which has three of its top 10 holdings in the medical device sector.

People are living longer and they want to remain active. Whether it is more durable knee replacements, less-invasive surgical tools, or artificial hearts – medical devices are the future of health care.

If we're in for a broad market decline, the case for medical device makers gets even stronger. Get into the best medical device stocks before the investment crowd recognizes the potential here, and you'll make large, safe gains all year... no matter where the S&P goes.

Good investing,

Rob Fannon

P.S. Next Wednesday, March 14, my research partner (Dr. George Huang) and I will be releasing our full report on the best medical device investment in the world right now. This company owns a breakthrough technology that is already FDA-approved… and has been used on more than 450,000 patients in hospitals all over America. For all of the details, click here.

David Einhorn quits New Century Financial Board
Greenlight Capital LLC founder David Einhorn resigned from the board of New Century Financial Corp., a subprime mortgage lender facing a criminal probe of its accounting and a credit crunch that might put it out of business.

Einhorn, 38, resigned yesterday, according to a Greenlight filing with the U.S. Securities and Exchange Commission. His New York-based hedge fund holds a 6.3 percent stake according to today's filing. At current prices, those shares may be valued at about $140 million less than when he joined the board of the Irvine, California-based company a year ago. Read on…

Suspicious Trading in London
Suspicious trading occurred ahead of nearly a quarter of all merger and acquisition deals on the London stock market in 2005, according to a study released on Wednesday by the UK Financial Services Authority, which adds to global regulatory concerns that illegal insider trading is widespread.

US authorities do not keep statistics in the same way, but they have expressed similar fears about insider trading. The New York Stock Exchange referred twice as many suspicious trades to US regulators for possible investigation in 2006 as it did in 2004, and federal prosecutors have recently broken up two separate trading rings that allegedly capitalised on M&A information from Wall Street banks. FT ($) Read on…


Strong agricultural prices boost fertilizer producer Terra Industries to another new high.

Another chance to get short emerging markets? Many foreign ETFs rallying back to their 50-day moving averages.

A stealth bull market in electrical and telecom infrastructure… new highs for Quanta Services and Dycom.

In the news: Superstar investor gives up on busted subprime lender.
Last Change 52-Wk
S&P 500 1391.97 -0.25% 9.10%
Oil (USO)* 51.27 1.89% -24.43%
Gold (GLD) 64.35 0.31% 17.11%
Silver (SLV)* 129.00 0.03% -6.60%
US Dollar 83.75 -0.29% -7.60%
Euro 1.318 0.34% 10.78%
VIX 15.96 -18.70% 25.27%
HUI 328.31 4.27% 7.11%
10-year yield 4.53% 0.01 -0.21
* Since ETF inception

"SNiP Technique" now used in EVERY major hospital–could make early investors 1,500%

It’s not a drug or pill, but a new FDA-approved technology that could lower your blood pressure and even prevent Alzheimer’s.

** The Economist says it "will revolutionize the entire healthcare system."

** Dr. Francis Collins of the National Institutes of Health calls it a "historic movement... a revolution."

This breakthrough has already brought some investors returns of 1,500%--but the biggest gains are still to come...

Click here for the full details

Company Sym Industry

Bruker BioSciences

BRKR

medical equip

MEDTOX Scientific

MTOX

medical research

Clinical Data Inc

CLDA

medical equip

Dycom

DY

construction

Bally Technologies

BYI

gaming

Saul Centers

BFS

REIT

Ryerson

RYI

metals

General Maritime

GMR

shipping

TeleTech Holdings

TTEC

business srvcs

Goodyear Tire

GT

rubber products

Tesco

TESOF

oil services

Friendly Ice Cream

FRN

restaurants

Golden Star

GSS

gold

Innospec

IOSP

chemicals

Makita

MKTAY

tools

Vail Resorts

MTN

resorts

TRW Automotive

TRW

auto parts

Men's Wearhouse

MW

clothing

Boardwalk Pipeline

BWP

oil & gas pipeline

First American Corp

FAF

business srvcs

Ivanhoe Mines

IVN

mining

Mattel

MAT

toys

Quanta Services

PWR

contracting

Sturm, Ruger

RGR

guns

Terra Industries

TRA

agriculture

Dawson Geophysical

DWSN

oil services

Company Sym Industry

Whitney Holding

WTNY

bank

McClatchy

MNI

newspapers

Laclede Group

LG

utilities

Mobile Mini

MINI

storage units

Vonage

VG

telecom

I.D. Systems

IDSY

RFID

Nobility Homes

NOBH

manufact homes

Micron Technology

MU

semiconductors

Home | About GSW | FAQ | GSW Archive | Privacy Policy | Contact Us

Customer Service: 1-888-261-2693 – Copyright 2008 Stansberry & Associates Investment Research. All Rights Reserved. Protected by copyright laws of the United States and international treaties. This e-letter may only be used pursuant to the subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of Stansberry & Associates Investment Research, LLC. 1217 Saint Paul Street, Baltimore MD 21202